Cartotto R et al: SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center. J Burn Care Res 29:141, 2008.
Auquier-Dunant A et al: Correlation between clinical patterns and causes of erythema multiforme major, Stevens Johnson and toxic epidermal necrolysis. Arch Dermatol 138:1019, 2002.
Rzany B et al: Epidemiology of erythema exudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990 1992): Structure and results of a population-based registry. J Clin Epidemiol 49 :769, 1996.
Dodiuk-Gad RP, Olteanu C, Jeschke MG, Cartotto R, Fish J, Shear NH. Treatment of toxic epidermal necrolysis in North America. J Am Acad Dermatol. 2015 Nov;73(5):876-7.e2
Fine J.D: Management of acquired bullous skin diseases. N Engl J Med 1995; 333: 1475 1484
Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol. 2013 Aug;69(2):187.e1-16; quiz 203-4.
Kardaun S.H., Jonkman M.F Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 2007; 87: 144 148.
Huang YC, Li YC, Chen TJ. The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. Br J Dermatol. 2012 Aug;167(2):424-32.
Barron SJ, Del Vecchio MT, Aronoff SC. Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies. Int J Dermatol. 2015 Jan;54(1):108-15.
Lee HY, Fook-Chong S, Koh HY, Thirumoorthy T, Pang SM Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center. J Am Acad Dermatol. 2016 Oct 4. pii: S0190-9622(16)30600-4.
Prabhasawat P, Tesavibul N, Karnchanachetanee C, Kasemson S.Efficacy of cyclosporine 0.05% eye drops in Stevens Johnson syndrome with chronic dry eye. J Ocul Pharmacol Ther. 2013 Apr;29(3):372-7.
Del Pozzo-Magana BR, Lazo-Langer A, Carleton B, Castro-Pastrana LI, Rieder MJ. A systematic review of the treatment of drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Parmacol. 2011;18(1):e121-33.
Жерносек В.Ф., Дюбкова Т.П. Клиническая классификация и критерии диагностики синдрома Стивенса-Джонсона токсического эпидермального некролиза у детей: обзор иностранной литературы. Педиатрия. Восточная Европа. 2014. № 1 (5). С. 118-133.
Sekula P, Dunant A, Mockenhaupt M, Naldi L. et al. RegiSCAR study group Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133(5):1197 1204.
Roujeau JC, Bastuji-Garin S. Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality. TherAdv Drug Saf. 2011;2(3):87.
Schneider JA, Cohen PR. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.AdvTher. 2017; 34(6): 1235 1244.
А. Л. Верткин, А. В. Дадыкина «Синдром Стивенса Джонсона»,Лечащий рач №42006-04-28
Maja Mockenhaupt Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management 2Semin Cutan Med Surg .2014
Лоуэлла А.Голдсмит,Стивен И.Кац ,Барбара А.Джилкрест ,Дермаьология Фицпатрика в клинической практике ,издание второе стр 490
Е.В.Боровский,А.Л.Машкиллейсон Заболевания слизистой оболочки полости рта и губ стр 194
С.И.Барденикова,О.С.Пеньтковская,Е.К.Исаева
Синдром Стивенса — Джонсона — иммунная катастрофа РМЖ. Мать и дитя №1 от 28.02.2019 стр. 66-72
Т.П.Дюбкова,В.Ф.Жерносек«Синдром Стивенса-Джонсона токсический эпидермальный некролиз у детей»